Evidence map›Paper›PMID 39762653›Full record

ArticleMolecular systems biology2025

Author Correction: Systematic protein-protein interaction mapping for clinically relevant human GPCRs.

Kate Sokolina, Saranya Kittanakom, Jamie Snider, Max Kotlyar, Pascal Maurice, Jorge Gandía, Abla Benleulmi-Chaachoua, Kenjiro Tadagaki, Atsuro Oishi, Victoria Wong and 18 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular systems biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

Kate Sokolina *Donnelly Centre, University of Toronto, Toronto, M5S 3E1, Canada.
Saranya Kittanakom *Donnelly Centre, University of Toronto, Toronto, M5S 3E1, Canada.
Jamie Snider *Donnelly Centre, University of Toronto, Toronto, M5S 3E1, Canada.
Max KotlyarPrincess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, M5G 1L7, Canada.
Pascal MauriceInserm, U1016, Institut Cochin, Paris, France.ORCID http://orcid.org/0000-0003-2167-4808
Jorge GandíaUnitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, 08901, Spain.ORCID http://orcid.org/0000-0003-1711-8075
Abla Benleulmi-ChaachouaInserm, U1016, Institut Cochin, Paris, France.
Kenjiro TadagakiInserm, U1016, Institut Cochin, Paris, France.
Atsuro OishiInserm, U1016, Institut Cochin, Paris, France.
Victoria WongDonnelly Centre, University of Toronto, Toronto, M5S 3E1, Canada.
Ramy H MaltyDepartment of Biochemistry, Research and Innovation Centre, University of Regina, Regina, S4S 0A2, Canada.
Viktor DeinekoDepartment of Biochemistry, Research and Innovation Centre, University of Regina, Regina, S4S 0A2, Canada.
Hiroyuki AokiDepartment of Biochemistry, Research and Innovation Centre, University of Regina, Regina, S4S 0A2, Canada.
Shahreen AminDepartment of Biochemistry, Research and Innovation Centre, University of Regina, Regina, S4S 0A2, Canada.
Zhong YaoDonnelly Centre, University of Toronto, Toronto, M5S 3E1, Canada.
Xavier MoratóUnitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, 08901, Spain.
David OtasekPrincess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, M5G 1L7, Canada.
Hiroyuki KobayashiDepartment of Biochemistry, Institute for Research in Immunology & Cancer, Université de Montréal, Montréal, H3T 1J4, Canada.
Javier MenendezDonnelly Centre, University of Toronto, Toronto, M5S 3E1, Canada.
Daniel AuerbachDualsystems Biotech AG, Schlieren, 8952, Switzerland.
Stephane AngersDepartment of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy and Department of Biochemistry, Faculty of Medicine, University of Toronto, Toronto, M5S 3M2, Canada.
Natasa PržuljDepartment of Computing, University College London, London, WC1E 6BT, UK.
Michel BouvierDepartment of Biochemistry, Institute for Research in Immunology & Cancer, Université de Montréal, Montréal, H3T 1J4, Canada.
Mohan BabuDepartment of Biochemistry, Research and Innovation Centre, University of Regina, Regina, S4S 0A2, Canada.
Francisco CiruelaUnitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, 08901, Spain.
Ralf JockersInserm, U1016, Institut Cochin, Paris, France.
Igor JurisicaPrincess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, M5G 1L7, Canada.ORCID http://orcid.org/0000-0002-2507-946X
Igor StagljarDonnelly Centre, University of Toronto, Toronto, M5S 3E1, Canada. igor.stagljar@utoronto.ca.ORCID http://orcid.org/0000-0002-5260-3327

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39762653
PMCPMC11790839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.